These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19965859)

  • 1. Anti-GM1 IgG antibodies in Guillain-Barré syndrome: fine specificity is associated with disease severity.
    Lardone RD; Yuki N; Odaka M; Daniotti JL; Irazoqui FJ; Nores GA
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):629-33. PubMed ID: 19965859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-ganglioside complex antibodies associated with severe disability in GBS.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
    Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual Restriction Of Fine Specificity Variability In Anti-GM1 IgG Antibodies Associated With Guillain-Barré Syndrome.
    Lardone RD; Yuki N; Irazoqui FJ; Nores GA
    Sci Rep; 2016 Jan; 6():19901. PubMed ID: 26818965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
    Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
    J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential immune response to gangliosides in Guillain-Barré syndrome patients from Japan and The Netherlands.
    Ang CW; Koga M; Jacobs BC; Yuki N; van der Meché FG; van Doorn PA
    J Neuroimmunol; 2001 Dec; 121(1-2):83-7. PubMed ID: 11730944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High affinity of anti-GM1 antibodies is associated with disease onset in experimental neuropathy.
    Comín R; Yuki N; Lopez PH; Nores GA
    J Neurosci Res; 2006 Oct; 84(5):1085-90. PubMed ID: 16881049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy.
    Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K
    J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
    Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
    Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiganglioside antibodies are associated with axonal Guillain-Barré syndrome: a Japanese-Italian collaborative study.
    Sekiguchi Y; Uncini A; Yuki N; Misawa S; Notturno F; Nasu S; Kanai K; Noto Y; Fujimaki Y; Shibuya K; Ohmori S; Sato Y; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):23-8. PubMed ID: 22010183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganglioside-specific IgG and IgA recruit leukocyte effector functions in Guillain-Barré syndrome.
    van Sorge NM; Yuki N; Koga M; Susuki K; Jansen MD; van Kooten C; Wokke JH; van de Winkel JG; van der Pol WL; van den Berg LH
    J Neuroimmunol; 2007 Jan; 182(1-2):177-84. PubMed ID: 17156858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.
    Kusunoki S; Morita D; Ohminami S; Hitoshi S; Kanazawa I
    Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies.
    Ang CW; Yuki N; Jacobs BC; Koga M; Van Doorn PA; Schmitz PI; Van Der Meché FG
    Neurology; 1999 Dec; 53(9):2122-7. PubMed ID: 10599792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptococcal IdeS: therapeutic potential for Guillain-Barré syndrome.
    Takahashi R; Yuki N
    Sci Rep; 2015 Jul; 5():10809. PubMed ID: 26194472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
    Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
    J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Range of cross reactivity of anti-GM1 IgG antibody in Guillain-Barré syndrome.
    Koga M; Tatsumoto M; Yuki N; Hirata K
    J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):123-4. PubMed ID: 11413278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.